Close

Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease

Go back to Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimer’s Disease
(NASDAQ: QTRX) Delayed: 16.10 -0.2 (1.23%)
Previous Close $16.30    52 Week High
Open $16.13    52 Week Low
Day High $17.08    P/E N/A 
Day Low $16.07    EPS
Volume 409,256